Applied DNA Corp (APDN) - מזומנים למניה אחת

Applied DNA Sciences develops PCR solutions and product authentication methods. Cash per share for the company reflects liquidity dynamics, with the current value equal to 3.66. Experienced executives are successfully implementing DNA tagging in medicine; however, the project-based nature of sales and high promotion expenses lead to capital burn, hindering the formation of a stable free cash flow.
פילוחי מדדים מקיפים ואנליטיקה עבור Applied DNA Sciences Inc (APDN)

Liquidity is critical for Applied DNA Sciences (APDN) due to its reliance on government contracts for PCR testing and DNA tagging. This metric is calculated by dividing the total amount of free cash flow by the number of shares outstanding. By analyzing the cash per share value, an investor determines the portion of liquidity available to cover operating expenses. This chart reflects the company's ability to fund production amid volatile demand, allowing for an objective assessment of the issuer's financial stability.